242 related articles for article (PubMed ID: 15819880)
1. 14-3-3 proteins regulate glycogen synthase 3beta phosphorylation and inhibit cardiomyocyte hypertrophy.
Liao W; Wang S; Han C; Zhang Y
FEBS J; 2005 Apr; 272(8):1845-54. PubMed ID: 15819880
[TBL] [Abstract][Full Text] [Related]
2. Activation of peroxisome proliferator-activated receptor-alpha prevents glycogen synthase 3beta phosphorylation and inhibits cardiac hypertrophy.
Li R; Zheng W; Pi R; Gao J; Zhang H; Wang P; Le K; Liu P
FEBS Lett; 2007 Jul; 581(17):3311-6. PubMed ID: 17597616
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of 14-3-3 proteins on serum-induced proliferation of cardiac fibroblasts.
Du J; Liao W; Wang Y; Han C; Zhang Y
Eur J Cell Biol; 2005 Oct; 84(10):843-52. PubMed ID: 16270752
[TBL] [Abstract][Full Text] [Related]
4. The AMPK gamma1 R70Q mutant regulates multiple metabolic and growth pathways in neonatal cardiac myocytes.
Folmes KD; Witters LA; Allard MF; Young ME; Dyck JR
Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3456-64. PubMed ID: 17906100
[TBL] [Abstract][Full Text] [Related]
5. Nerve growth factor (NGF) regulates activity of nuclear factor of activated T-cells (NFAT) in neurons via the phosphatidylinositol 3-kinase (PI3K)-Akt-glycogen synthase kinase 3β (GSK3β) pathway.
Kim MS; Shutov LP; Gnanasekaran A; Lin Z; Rysted JE; Ulrich JD; Usachev YM
J Biol Chem; 2014 Nov; 289(45):31349-60. PubMed ID: 25231981
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-Akt-GATA4 signaling pathway in cardiomyocytes.
Chandrasekar B; Mummidi S; Claycomb WC; Mestril R; Nemer M
J Biol Chem; 2005 Feb; 280(6):4553-67. PubMed ID: 15574430
[TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase 3beta inhibits myocardin-dependent transcription and hypertrophy induction through site-specific phosphorylation.
Badorff C; Seeger FH; Zeiher AM; Dimmeler S
Circ Res; 2005 Sep; 97(7):645-54. PubMed ID: 16141410
[TBL] [Abstract][Full Text] [Related]
8. Glycogen synthase kinase-3beta is involved in the process of myocardial hypertrophy stimulated by insulin-like growth factor-1.
Seimi SK; Seinosuke K; Tsuyoshi S; Tomomi U; Tetsuaki H; Miki K; Ryuji T; Kenji I; Mitsuhiro Y
Circ J; 2004 Mar; 68(3):247-53. PubMed ID: 14993781
[TBL] [Abstract][Full Text] [Related]
9. Anti-hypertrophic effect of NHE-1 inhibition involves GSK-3beta-dependent attenuation of mitochondrial dysfunction.
Javadov S; Rajapurohitam V; Kilić A; Zeidan A; Choi A; Karmazyn M
J Mol Cell Cardiol; 2009 Jun; 46(6):998-1007. PubMed ID: 19318234
[TBL] [Abstract][Full Text] [Related]
10. Reoxygenation after severe hypoxia induces cardiomyocyte hypertrophy in vitro: activation of CREB downstream of GSK3beta.
El Jamali A; Freund C; Rechner C; Scheidereit C; Dietz R; Bergmann MW
FASEB J; 2004 Jul; 18(10):1096-8. PubMed ID: 15155564
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of eukaryotic translation initiation factor 2Bepsilon by glycogen synthase kinase-3beta regulates beta-adrenergic cardiac myocyte hypertrophy.
Hardt SE; Tomita H; Katus HA; Sadoshima J
Circ Res; 2004 Apr; 94(7):926-35. PubMed ID: 15001529
[TBL] [Abstract][Full Text] [Related]
12. Regulation of glycogen synthase kinase-3beta by products of lipid peroxidation in human neuroblastoma cells.
Dozza B; Smith MA; Perry G; Tabaton M; Strocchi P
J Neurochem; 2004 Jun; 89(5):1224-32. PubMed ID: 15147515
[TBL] [Abstract][Full Text] [Related]
13. Regulation of hypoxia-inducible factor-1alpha protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta pathway in HepG2 cells.
Mottet D; Dumont V; Deccache Y; Demazy C; Ninane N; Raes M; Michiels C
J Biol Chem; 2003 Aug; 278(33):31277-85. PubMed ID: 12764143
[TBL] [Abstract][Full Text] [Related]
14. NT3 inhibits FGF2-induced neural progenitor cell proliferation via the PI3K/GSK3 pathway.
Jin L; Hu X; Feng L
J Neurochem; 2005 Jun; 93(5):1251-61. PubMed ID: 15934945
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
[TBL] [Abstract][Full Text] [Related]
16. KMUP-1 Attenuates Endothelin-1-Induced Cardiomyocyte Hypertrophy through Activation of Heme Oxygenase-1 and Suppression of the Akt/GSK-3β, Calcineurin/NFATc4 and RhoA/ROCK Pathways.
Liou SF; Hsu JH; Chen YT; Chen IJ; Yeh JL
Molecules; 2015 Jun; 20(6):10435-49. PubMed ID: 26056815
[TBL] [Abstract][Full Text] [Related]
17. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L
Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234
[TBL] [Abstract][Full Text] [Related]
18. H2O2-induced phosphorylation of ERK1/2 and PKB requires tyrosine kinase activity of insulin receptor and c-Src.
Mehdi MZ; Pandey NR; Pandey SK; Srivastava AK
Antioxid Redox Signal; 2005; 7(7-8):1014-20. PubMed ID: 15998256
[TBL] [Abstract][Full Text] [Related]
19. Glycogen synthase kinases 3alpha and 3beta in cardiac myocytes: regulation and consequences of their inhibition.
Markou T; Cullingford TE; Giraldo A; Weiss SC; Alsafi A; Fuller SJ; Clerk A; Sugden PH
Cell Signal; 2008 Jan; 20(1):206-18. PubMed ID: 17993264
[TBL] [Abstract][Full Text] [Related]
20. Urocortin-induced cardiomyocytes hypertrophy is associated with regulation of the GSK-3β pathway.
Gruson D; Ginion A; Decroly N; Lause P; Vanoverschelde JL; Ketelslegers JM; Bertrand L; Thissen JP
Heart Vessels; 2012 Mar; 27(2):202-7. PubMed ID: 21505854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
